Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.
NCT00200928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2006-04-04
Summary
The degree of TH1-skewing by mycobacteria is controlles by NRAMP1 gene polymorphisms and related to the degree of inhibition of TH2-mediated disease.
Conditions
- Food Allergy
- Atopic Dermatitis
- Asthma
- Rhinitis
Interventions
- BIOLOGICAL
Sponsors & Collaborators
-
The Netherlands Asthma Foundation
lead OTHER
Principal Investigators
-
Maarten O Hoekstra, MD PhD · Wilhelmina Children's Hospital Utrecht (UMCU)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-01-31
- Completion
- 2005-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
NCT01326494 ·Status: COMPLETED ·Phase: PHASE4
-
ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression
NCT06869382 ·Status: COMPLETED ·Phase: PHASE4
-
Stress, Environment, and Genetics in Urban Children With Asthma
NCT00269256 ·Status: COMPLETED
-
Home Based Environmental Adherence Trial
NCT00005523 ·Status: COMPLETED
-
Azithromycin for Children Hospitalized With Asthma
NCT02003911 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
NCT00569192 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma in Children
NCT01286532 ·Status: COMPLETED
-
Characterising the Microbiota in Asthma
NCT02671773 ·Status: COMPLETED
-
Exposure of Children With Asthma to Household Environmental Tobacco Smoke
NCT00035685 ·Status: COMPLETED
-
Characterization of the Role of Histamine in Children With Asthma
NCT01392859 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Fluctuation of Airway Function in Children With Asthma
NCT02252289 ·Status: COMPLETED
-
Pharmacogenetics Use For Further Treatment Improvement in childreN
NCT03654508 ·Status: COMPLETED ·Phase: NA
-
Predicting the Response to Montelukast by Genetic Variation in Asthmatics
NCT00116324 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
NCT00546143 ·Status: COMPLETED ·Phase: PHASE4
-
Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms
NCT05028153 ·Status: RECRUITING ·Phase: PHASE2
-
Soluble CD23 Expression in Asthma Patients Treated With OMA
NCT00226200 ·Status: TERMINATED ·Phase: NA
-
Antibiotic Treatment of Recurrent Episodes of Asthma in Children
NCT01233297 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinico-biological Correlation of Severe Asthma in Children
NCT02038374 ·Status: UNKNOWN ·Phase: NA
-
Respiratory Dysbiosis in Preschool Children with Asthma: Predictive of a Severe Form
NCT05192499 ·Status: RECRUITING ·Phase: NA
-
Factors Influencing Pediatric Asthma
NCT03302962 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
NCT00670930 ·Status: COMPLETED ·Phase: PHASE4
-
Predicting Factors for Asthma Remission in Children
NCT02531503 ·Status: COMPLETED
-
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
NCT00213252 ·Status: COMPLETED ·Phase: PHASE2
-
C1-inhibitor in Allergic ASThma Patients
NCT03051698 ·Status: TERMINATED ·Phase: PHASE4